Related Experiment Video
Updated: Jun 28, 2026

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
[MELAS syndrome as a differential diagnosis of ischemic stroke]
1Krankenanstalt Rudolfstiftung, Wien, Osterreich. fifigs1@yahoo.de
Abstract:
Mitochondrial encephalomyopathy, lactacidosis and stroke-like episode (MELAS) syndrome is a phenotypically and genetically heterogeneous mitochondrial disorder with a clinical onset between the first and third decade. The clinical hallmark is the stroke-like-episode, which mimicks ischemic stroke but is usually transient and non-disabling in nature. The morphological equivalent on MRI is a T2-hyperintensity, predominantly over the temporo-parieto-occipital region, not confined to a vascular territory, which is also hyperintense on diffusion weighted imaging and on apparent diffusion coefficient sequences (vasogenic edema, stroke-like lesion). Additional features include seizures, cognitive decline, psychosis, lactic acidosis, migraine, visual impairment, hearing loss, short stature, diabetes, or myopathy. Muscle biopsy typically shows ragged-red fibers, COX-negative fibers, SDH hyperreactivity, and abnormally shaped mitochondria with paracristalline inclusions. The diagnosis is confirmed by demonstration of a biochemical respiratory chain defect or one of the disease-causing mutations, of which 80 % affect the mitochondrial tRNALeu gene.
Insights
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is a rare genetic disorder affecting energy production. Diagnosis involves identifying specific genetic mutations and characteristic MRI findings of stroke-like lesions.
Area of Science:
- Neurology
- Genetics
- Mitochondrial Biology
Context:
- Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome presents with diverse neurological and systemic symptoms.
- Characterized by stroke-like episodes mimicking ischemic events, these lesions are typically transient and not confined to vascular territories.
- Onset usually occurs between the first and third decades of life.
Purpose:
- To provide a comprehensive overview of MELAS syndrome, encompassing its clinical presentation, diagnostic criteria, and underlying pathophysiology.
- To highlight the key diagnostic features, including characteristic MRI findings and muscle biopsy results.
- To discuss the genetic basis of MELAS, focusing on common mutations.
Summary:
- MELAS syndrome is a heterogeneous mitochondrial disorder with stroke-like episodes as a hallmark.
- Clinical features include seizures, cognitive decline, lactic acidosis, and myopathy.
- Diagnosis is confirmed by genetic testing for mutations, often in the mitochondrial tRNALeu gene, and biochemical analysis of respiratory chain defects.
Impact:
- Enhances understanding of MELAS syndrome for clinicians and researchers.
- Facilitates earlier and more accurate diagnosis of MELAS.
- Contributes to the knowledge base for developing targeted therapies for mitochondrial disorders.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Hemorrhagic Stroke l: Introduction

